531210 — Colinz Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Colinz Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	PRESS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	26	46.8	52.1	57.3	70
Net Total Accounts Receivable
Net Total Receivables	14.9	13	12.1	11.3	8.59
Total Inventory
Total Other Current Assets
Total Current Assets	58.4	72.7	73.8	78.4	87.4
Net Property, Plant And Equipment	20.6	20.3	18.6	17.1	15.8
Long Term Investments
Long Term Notes Receivable
Total Assets	88.1	101	99.3	102	114
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	16.1	25.9	19.8	18.9	21.8
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	19.7	28.1	22.4	20.9	24.1
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	68.4	72.9	76.9	81.4	89.5
Total Liabilities & Shareholders' Equity	88.1	101	99.3	102	114
Total Common Shares Outstanding